Loading...

Julie Sneddon, PhD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentDiabetes Center
Address513 Parnassus Ave
San Francisco CA 94143
Phone415-502-3380
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cheng CW, Villani V, Buono R, Wei M, Kumar S, Yilmaz OH, Cohen P, Sneddon J, Perin L, Longo VD. Fasting-Mimicking Diet Promotes Ngn3-Driven ß-Cell Regeneration to Reverse Diabetes. Cell. 2017 Feb 23; 168(5):775-788.e12. PMID: 28235195.
      View in: PubMed
    2. Tajonar A, Maehr R, Hu G, Sneddon J, Rivera-Feliciano J, Cohen DE, Elledge SJ, Melton DA. Brief report: VGLL4 is a novel regulator of survival in human embryonic stem cells. Stem Cells. 2013 Dec; 31(12):2833-41. PMID: 23765749; PMCID: PMC4617635.
    3. Sneddon J, Borowiak M, Melton DA. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature. 2012 Nov 29; 491(7426):765-8. PMID: 23041930.
      View in: PubMed
    4. Sneddon J. The contribution of niche-derived factors to the regulation of cancer cells. Methods Mol Biol. 2009; 568:217-32. PMID: 19582430.
      View in: PubMed
    5. Sneddon J, Werb Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell. 2007 Dec 13; 1(6):607-11. PMID: 18371402; PMCID: PMC2571117.
    6. Welm AL, Sneddon J, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH, Bishop JM. The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A. 2007 May 1; 104(18):7570-5. PMID: 17456594; PMCID: PMC1855278.
    7. Scharpf RB, Iacobuzio-Donahue CA, Sneddon J, Parmigiani G. When should one subtract background fluorescence in 2-color microarrays? Biostatistics. 2007 Oct; 8(4):695-707. PMID: 17164465.
      View in: PubMed
    8. Sneddon J, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A. 2006 Oct 3; 103(40):14842-7. PMID: 17003113; PMCID: PMC1578503.
    9. Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon J, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res. 2006; 8(5):R62. PMID: 17069664; PMCID: PMC1779489.
    10. Chang HY, Nuyten DS, Sneddon J, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A. 2005 Mar 8; 102(10):3738-43. PMID: 15701700; PMCID: PMC548329.
    11. Chang HY, Sneddon J, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004 Feb; 2(2):E7. PMID: 14737219; PMCID: PMC314300.
    Julie's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP